- Home
- ATHA vs WETH Comparison
ATHA vs WETH Comparison
Compare ATHA & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- WETH
- Stock Information
- Founded
- ATHA 2011
- WETH 1992
- Country
- ATHA United States
- WETH China
- Employees
- ATHA N/A
- WETH N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- WETH
- Sector
- ATHA Health Care
- WETH
- Exchange
- ATHA Nasdaq
- WETH Nasdaq
- Market Cap
- ATHA 21.0M
- WETH 21.5M
- IPO Year
- ATHA 2020
- WETH N/A
- Fundamental
- Price
- ATHA $0.53
- WETH $1.66
- Analyst Decision
- ATHA Buy
- WETH
- Analyst Count
- ATHA 4
- WETH 0
- Target Price
- ATHA $11.25
- WETH N/A
- AVG Volume (30 Days)
- ATHA 235.4K
- WETH 411.0K
- Earning Date
- ATHA 02-20-2025
- WETH 02-17-2025
- Dividend Yield
- ATHA N/A
- WETH N/A
- EPS Growth
- ATHA N/A
- WETH N/A
- EPS
- ATHA N/A
- WETH 0.34
- Revenue
- ATHA N/A
- WETH $41,024,264.00
- Revenue This Year
- ATHA N/A
- WETH N/A
- Revenue Next Year
- ATHA N/A
- WETH N/A
- P/E Ratio
- ATHA N/A
- WETH $4.83
- Revenue Growth
- ATHA N/A
- WETH 2.86
- 52 Week Low
- ATHA $0.41
- WETH $1.13
- 52 Week High
- ATHA $4.30
- WETH $5.70
- Technical
- Relative Strength Index (RSI)
- ATHA 41.88
- WETH 48.25
- Support Level
- ATHA $0.52
- WETH $1.48
- Resistance Level
- ATHA $0.57
- WETH $2.00
- Average True Range (ATR)
- ATHA 0.04
- WETH 0.15
- MACD
- ATHA -0.00
- WETH 0.01
- Stochastic Oscillator
- ATHA 11.82
- WETH 34.62
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.